Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

The efficacy of motivational counseling and SMS-reminders on daily sitting time in patients with rheumatoid arthritis: protocol for a randomized controlled trial.

Esbensen B, Thomsen T, Hetland ML, Beyer N, Midtgaard J, Løppenthin K, Jennum P, Østergaard M, Sørensen J, Christensen R, Aadahl M.

Trials. 2015 Jan 27;16(1):23. [Epub ahead of print]

PMID:
25623388
[PubMed - as supplied by publisher]
Free PMC Article
2.

The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers.

Kearsley-Fleet L, Závada J, Hetland ML, Nordström DC, Aaltonen KJ, Listing J, Zink A, Gati T, Rojkovich B, Iannone F, Gremese E, van Riel PL, van de Laar MA, Lie E, Kvien TK, Canhão H, Fonseca JE, Rotar Z, Loza E, Carmona L, Askling J, Johansson K, Finckh A, Dixon WG, Hyrich KL; on behalf of the EULAR Study Group for Registers and Observational Drug Studies.

Rheumatology (Oxford). 2014 Nov 27. pii: keu446. [Epub ahead of print]

PMID:
25433042
[PubMed - as supplied by publisher]
3.

Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study.

Rom AL, Wu CS, Olsen J, Kjaergaard H, Jawaheer D, Hetland ML, Vestergaard M, Mørch LS.

Arthritis Rheumatol. 2014 Dec;66(12):3265-73. doi: 10.1002/art.38874.

PMID:
25393524
[PubMed - indexed for MEDLINE]
4.

Monitoring patients with rheumatoid arthritis in routine care: experiences from a treat-to-target strategy using the DANBIO registry.

Hetland ML, Jensen DV, Krogh NS.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-141-6. Epub 2014 Oct 30.

PMID:
25365104
[PubMed - indexed for MEDLINE]
5.

CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients.

Ammitzbøll CG, Steffensen R, Bøgsted M, Hørslev-Petersen K, Hetland ML, Junker P, Johansen JS, Pødenphant J, Østergaard M, Ellingsen T, Stengaard-Pedersen K.

Arthritis Res Ther. 2014 Oct 31;16(5):475. doi: 10.1186/s13075-014-0475-3.

PMID:
25359432
[PubMed - in process]
Free PMC Article
6.

Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis.

Laustsen JK, Rasmussen TK, Stengaard-Pedersen K, Hørslev-Petersen K, Hetland ML, Østergaard M, Junker P, Hvid M, Deleuran B.

Arthritis Res Ther. 2014 Oct 30;16(5):474. doi: 10.1186/s13075-014-0474-4.

PMID:
25359291
[PubMed - in process]
Free PMC Article
7.

The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program.

Grøn KL, Ornbjerg LM, Hetland ML, Aslam F, Khan NA, Jacobs JW, Henrohn D, Rasker JJ, Kauppi MJ, Lang HC, Mota LM, Aggarwal A, Yamanaka H, Badsha H, Gossec L, Cutolo M, Ferraccioli G, Gremese E, Bong Lee E, Inanc N, Direskeneli H, Taylor P, Huisman M, Alten R, Pohl C, Oyoo O, Stropuviene S, Drosos AA, Kerzberg E, Ancuta C, Mofti A, Bergman M, Detert J, Selim ZI, Abda EA, Rexhepi B, Sokka T.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):869-77. Epub 2014 Oct 20.

PMID:
25327997
[PubMed - in process]
8.

Reply to eLetter by Feldtkeller et al.

Sørensen J, Hetland ML.

Ann Rheum Dis. 2014 Dec;73(12):e78. doi: 10.1136/annrheumdis-2014-206612. Epub 2014 Oct 3. No abstract available.

PMID:
25281722
[PubMed - indexed for MEDLINE]
9.

Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.

Ørnbjerg LM, Østergaard M, Bøyesen P, Krogh NS, Thormann A, Tarp U, Poulsen UE, Espesen J, Schlemmer A, Graudal N, Kollerup G, Jensen DV, Madsen OR, Glintborg B, Christensen T, Lindegaard H, Bøhme W, Hansen A, Andersen AR, Hetland ML.

J Rheumatol. 2014 Dec;41(12):2352-60. doi: 10.3899/jrheum.131299. Epub 2014 Oct 1.

PMID:
25274894
[PubMed - in process]
10.

CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic 'window of opportunity'.

Greisen SR, Schelde KK, Rasmussen TK, Kragstrup TW, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Deleuran B, Hvid M.

Arthritis Res Ther. 2014 Sep 24;16(5):434. doi: 10.1186/s13075-014-0434-z.

PMID:
25249397
[PubMed - in process]
Free PMC Article
11.

Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis.

Krol A, Garred P, Heegaard NH, Christensen AF, Hetland ML, Stengaard-Pedersen K, Junker P, Madsen HO, Lottenburger T, Ellingsen T, Andersen LS, Hansen I, Pedersen JK, Svendsen AJ, Tarp U, Pødenphant J, Lindegaard H, Østergaard M, Hørslev-Petersen K, Jacobsen S.

Scand J Rheumatol. 2015;44(1):8-12. doi: 10.3109/03009742.2014.918651. Epub 2014 Sep 10.

PMID:
25205362
[PubMed - in process]
12.

Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DANBIO registry.

Højgaard P, Glintborg B, Hetland ML, Hansen TH, Lage-Hansen PR, Petersen MH, Holland-Fischer M, Nilsson C, Loft AG, Andersen BN, Adelsten T, Jensen J, Omerovic E, Christensen R, Tarp U, Ostgård R, Dreyer L.

Ann Rheum Dis. 2014 Jul 25. pii: annrheumdis-2014-205389. doi: 10.1136/annrheumdis-2014-205389. [Epub ahead of print]

PMID:
25063827
[PubMed - as supplied by publisher]
13.

Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome.

Sode J, Vogel U, Bank S, Andersen PS, Thomsen MK, Hetland ML, Locht H, Heegaard NH, Andersen V.

PLoS One. 2014 Jun 26;9(6):e100361. doi: 10.1371/journal.pone.0100361. eCollection 2014.

PMID:
24967817
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO.

Glintborg B, Gudbjornsson B, Krogh NS, Omerovic E, Manilo N, Holland-Fischer M, Lindegaard HM, Loft AG, Nordin H, Johnsen L, Oeftiger SF, Hansen A, Rasmussen C, Grondal G, Geirsson AJ, Hetland ML.

Rheumatology (Oxford). 2014 Nov;53(11):2100-9. doi: 10.1093/rheumatology/keu252. Epub 2014 Jun 17.

PMID:
24939677
[PubMed - indexed for MEDLINE]
15.

Decreases in diagnostic delay are supported by sensitivity analyses.

Sørensen J, Hetland ML.

Ann Rheum Dis. 2014 Jul;73(7):e45. doi: 10.1136/annrheumdis-2014-205590. Epub 2014 Apr 16. No abstract available.

PMID:
24739326
[PubMed - indexed for MEDLINE]
16.

Contact frequency, travel time, and travel costs for patients with rheumatoid arthritis.

Sørensen J, Linde L, Hetland ML.

Int J Rheumatol. 2014;2014:285951. doi: 10.1155/2014/285951. Epub 2014 Feb 17.

PMID:
24693288
[PubMed]
Free PMC Article
17.

Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry.

Sørensen J, Hetland ML; all departments of rheumatology in Denmark.

Ann Rheum Dis. 2015 Mar;74(3):e12. doi: 10.1136/annrheumdis-2013-204867. Epub 2014 Feb 17.

PMID:
24534758
[PubMed - in process]
Free Article
18.

A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.

Axelsen MB, Eshed I, Hørslev-Petersen K, Stengaard-Pedersen K, Hetland ML, Møller J, Junker P, Pødenphant J, Schlemmer A, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Dam MY, Hansen I, Horn HC, Ammitzbøll CG, Jørgensen A, Krintel SB, Raun J, Krogh NS, Johansen JS, Ostergaard M; OPERA study group.

Ann Rheum Dis. 2014 Jan 16. doi: 10.1136/annrheumdis-2013-204537. [Epub ahead of print]

PMID:
24412895
[PubMed - as supplied by publisher]
19.

Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity.

Gandjbakhch F, Haavardsholm EA, Conaghan PG, Ejbjerg B, Foltz V, Brown AK, Døhn UM, Lassere M, Freeston JE, Olsen IC, Bøyesen P, Bird P, Fautrel B, Hetland ML, Emery P, Bourgeois P, Hørslev-Petersen K, Kvien TK, McQueen FM, Østergaard M.

J Rheumatol. 2014 Feb;41(2):398-406. doi: 10.3899/jrheum.131088. Epub 2013 Dec 15.

PMID:
24334647
[PubMed - indexed for MEDLINE]
20.

Differentiation between early rheumatoid arthritis patients and healthy persons by conventional and dynamic contrast-enhanced magnetic resonance imaging.

Axelsen MB, Ejbjerg BJ, Hetland ML, Skjødt H, Majgaard O, Lauridsen UB, Hørslev-Petersen K, Boesen M, Kubassova O, Bliddal H, Østergaard M.

Scand J Rheumatol. 2014;43(2):109-18. doi: 10.3109/03009742.2013.824022. Epub 2013 Nov 6.

PMID:
24191910
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk